bempegaldesleukin,nivolumab
bms,nektar
['bempeg', 'opdivo', 'melanoma', 'bmsnews', 'nektar', 'bristol']
#esmo22: adding bempeg to opdivo lowered response rate in bristol myers-nektar failed cancer trial - more like this | #melanoma #clinicaltrial #clinicaldata #immunooncology #opdivo #biotech 
Business intelligence for biotechs. We help #biotech innovators, investors, and business partners connect.